Key result
Septal reduction strategies for HOCM lack specific short-term outcome and cost results in this abstract.
Why the study?
Differences in short-term outcomes and hospital-based resource utilization between septal reduction strategies for obstructive hypertrophic cardiomyopathy were not well characterized.
Do different septal reduction strategies affect short-term outcomes and resource utilization in adults with obstructive hypertrophic cardiomyopathy?
Do different septal reduction strategies affect short-term outcomes and resource utilization in adults with obstructive hypertrophic cardiomyopathy?
Answers are grounded in this paper and cite their sources.
Observational data on septal reduction strategies leave short-term outcomes and resource use unresolved; randomized trials needed.
In this retrospective observational analysis of the United States Nationwide Readmissions Database years 2012-2014, we identified adults who underwent isolated septal reduction (SR) for OHCM. We studied the differences in short-term outcomes (inpatient mortality and 90-day readmission rate) and in-hospital resource utilization (LOS and costs) between the SR strategies.
No takes yet. Share an insight, caveat, or question.
Yandrapalli et al. (2021) studied this question. Septal reduction strategies for hypertrophic obstructive cardiomyopathy were evaluated for short-term outcomes and resource utilization, though the abstract lacks specific results.
Synapse has enriched 10 related papers. Consider them for comparative context: